*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>LX4211 intermediates are critical synthetic precursors for the development of FXR/FGF19 agonists. These compounds undergo specific <strong>catalytic hydrogenation</strong> and <strong>coupling reactions</strong>. Molecular formula: C<sub>20</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>; CAS No.: 1689373-88-5.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Used in large-scale synthesis of obeticholic acid analogs.</li>
<li><strong>Research & Development:</strong> Employed in preclinical studies for metabolic disorders.</li>
<li><strong>Quality Control:</strong> Serves as reference standards for purity verification.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly limit exposure to <strong>human subjects</strong> outside approved clinical trials. Store under <strong>inert atmosphere</strong> at -20°C. Personnel must wear <strong>chemical-resistant PPE</strong> during handling.</p>